FDA Drug Application (202038) for PANTOPRAZOLE SODIUM by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number202038
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
DosageEQ 20MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePANTOPRAZOLE SODIUM
Active IngredientPANTOPRAZOLE SODIUM

Active IngredientCount
List of drugs with Active Ingredient PANTOPRAZOLE SODIUM3


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD